| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |